Get started
Author

Lucy Earl

Observed names: Earl, Lucy, L Earl, L. Earl
ORCID: 0009-0004-1770-0772
Observed ORCID: 0009-0004-1770-0772
OpenAlex ID: A5113112394
Multi‐Tissue Epigenetic and Gene Expression Analysis Combined With Epigenome Modulation Identifies RWDD2B as a Target of Osteoarthritis Susceptibility
2020 · Eleanor Parker, Ines M. J. Hofer, et al. · Arthritis & Rheumatology · 38
PDF
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study
2024 · John Anderson, Daniel Soteres, et al. · Allergy and Asthma Proceedings · 16
Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey
2023 · Paulos Gebrehiwet, Johan Brekke, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 14
PDF
Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey
2023 · Katie Stenson, Lasair O'Callaghan, et al. · Journal of the Neurological Sciences · 12
PDF
Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey
2024 · Katie Stenson, T. E. Fecteau, et al. · Journal of Neurology · 11
PDF
Pegcetacoplan in paroxysmal nocturnal haemoglobinuria: Its use, its clinical effectiveness, and its influence on health‐related quality of life and productivity
2023 · Koo Wilson, Carly Rich, et al. · European Journal Of Haematology · 10
PDF
Real-world outcomes in patients with hereditary angioedema prescribed lanadelumab versus other prophylaxis
2024 · John Anderson, Daniel Soteres, et al. · Allergy and Asthma Proceedings · 9
Pb2056: Prevalence of Clinically Significant Extravascular Hemolysis in Stable C5 Inhibitor-treated Patients With Pnh and Its Association With Disease Control, Quality of Life and Treatment Satisfaction
2023 · Austin Kulasekararaj, Jennifer Mellor, et al. · HemaSphere · 8
Long-Term Real-World Outcomes in Patients with Hereditary Angioedema Receiving Lanadelumab for 3 or More Years
2025 · William R. Lumry, Mark Davis-Lorton, et al. · International Archives of Allergy and Immunology · 4
PDF
Comparison of Hereditary Angioedema Among Patients of Different Races and Ethnicities in the United States: Data From a Real-World Study
2023 · John Anderson, Timothy Craig, et al. · Journal of Allergy and Clinical Immunology · 2
Real-World Treatment Outcomes in Patients With Hereditary Angioedema Receiving Lanadelumab or Other Long-Term Prophylaxis
2024 · William Lumry, Mark Davis-Lorton, et al. · Journal of Allergy and Clinical Immunology · 1
Real-World Treatment Outcomes of Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated with Pegcetacoplan and Complement Protein 5 Inhibitors (C5i)
2023 · Elaine M Majerus, Brian Mulherin, et al. · Blood · 1
POSB356 Health-Related Quality of Life across King's and Mitos Stages Among Amyotrophic Lateral Sclerosis Patients: Results from a Real-World Point-in-Time Survey
2022 · K Stenson, W Agnese, et al. · Value in Health · 1
PDF
Clinical Outcomes and Disease Management for Patients with Paroxysmal Nocturnal Haemoglobinuria in China: Results from a Real-World Study
2025 · Rong Fu, Hui Liu, et al. · Drugs - Real World Outcomes
PDF
Understanding The Reasons Not To Treat All HAE Attacks And Patient Satisfaction For On-Demand Treatment (ODT). Results From The HAE Wave II Disease Specific Program™ (DSP™) 2023
2024 · Joan Mendivil, John Anderson, et al. · Journal of Allergy and Clinical Immunology
Physician and Patient Agreement in the Perception of Hereditary Angioedema (HAE) Attacks and Their Management: Data From a Real-World Survey
2024 · Paula Busse, David Hinds, et al. · Journal of Allergy and Clinical Immunology
PCR15 Impact of Amyotrophic Lateral Sclerosis on Work and Daily Living: Results from a Real-World Survey
2023 · K. Stenson, J. Mellor, et al. · Value in Health
PDF
POSTER: MDS-539 Understanding the Real-World Clinical Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
2023 · Jesse Fishman, Carly Rich, et al. · Clinical Lymphoma Myeloma & Leukemia
MDS-539 Understanding the Real-World Clinical Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
2023 · Jesse Fishman, Carly Rich, et al. · Clinical Lymphoma Myeloma & Leukemia
Pb2043: Clinical Effectiveness, Treatment Use, Satisfaction and Impact on Quality-of-life of Pegcetacoplan Treatment for Patients With Paroxysmal Nocturnal Haemoglobinuria (pnh).
2023 · Koo Wilson, Carly Rich, et al. · HemaSphere
EE32 Impact of Amyotrophic Lateral Sclerosis Disease Progression on Health Care Resource Use and Health-Related Quality of Life Using MiToS Staging and ALSFRS-R: Analysis of a Real-World Cross-Sectional Survey
2023 · P. Gebrehiwet, J. Brekke, et al. · Value in Health
CO216 Understanding the Real-World Clinical Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
2023 · J. Fishman, C. Rich, et al. · Value in Health
PDF
Disease Burden and Physician-Reported Outcomes in Pediatric Patients With Hereditary Angioedema: Data From A Real-World Study
2023 · Raffi Tachdjian, Daniel Soteres, et al. · Journal of Allergy and Clinical Immunology
Physician and Patient Reported Outcomes by Hereditary Angioedema Type: Data From a Real-world Study
2022 · J. Anderson, D. Soteres, et al. · Annals of Allergy Asthma & Immunology
RWD47 Understanding Patient Characteristics and Healthcare Resource Utilization in HAE Patients Currently Prescribed Prophylactic Treatment
2022 · K Moran, S Juethner, et al. · Value in Health
PDF
Works count: 26
Citation count: 127
H-index: 8
I10-index: 6
Year
Topic
Type